Michael Belloy

Michael is interested in neurology, neuroimaging, genetics, ‘omics, and Alzheimer’s disease. Michael obtained his PhD in 2018 from the University of Antwerp for his work on neural dynamics in rodents, titled “Quasi-Periodic brain activity in mice and its significance in pre-clinical neuroimaging research”. He joined the Greicius lab in 2018 as a Postdoc and has since pursued studying the genetics of Alzheimer’s disease to improve understanding of the disease and identify potential novel drug targets. Michael is currently an Instructor, supported by a research fellowship from the Alzheimer’s Association (AARF), a Stanford ADRC developmental project, and a K99 career transition award. Across these projects, he wields a personalized medicine framework to elucidate genetic risk for Alzheimer’s disease across APOE, sex, age, and ancestry. Ultimately, Michael aims to become an independent principal investigator in the field of Alzheimer’s disease and related dementias.